Oregon Venture Fund

Customer.io surpasses $30m ARR and raises financing from Spectrum Equity

Retrieved on: 
Thursday, March 10, 2022
BigQuery, Verafin, Blog, Founder CEO, SurveyMonkey, Customer engagement, Communication, SMS, Android, PLG, Microsoft, Snowflake, WhatsApp, Amazon Redshift, Spectrum Equity, ARR, IOS, Growth, Oregon Venture Fund, LinkedIn Learning, SDK, CEO, SQL Server, Video game, Mobile phone, Video game console, GoodRx

Customer.io raises financing from Spectrum Equity with participation from Oregon Venture fund.

Key Points: 
  • Customer.io raises financing from Spectrum Equity with participation from Oregon Venture fund.
  • Customer.io ended 2021 profitable for the year with annual recurring revenue (ARR) of $29.9m, up 78% from a year ago, and has now surpassed $30m ARR.
  • Colin adds, I chose Spectrum Equity because they understood the nuance of our business and are proven partners of founder-led businesses.
  • Spectrum Equity is a leading growth equity firm providing capital and strategic support to innovative companies in the information economy.

Social Emotional and Life Readiness Provider Wayfinder Closes $6.6 Million Series A Round

Retrieved on: 
Wednesday, January 5, 2022
Adolescence, Stanford University, Perseverance, Problem solving, Traction, Research, Communication, Education, Oregon Venture Fund, Life, 21st century skills, Student, School, Google, Neuroscience, Curriculum, Empathy, Management, Medicine, K12, Wayfinder

BERKELEY, Calif., Jan. 5, 2022 /PRNewswire-PRWeb/ -- Wayfinder , a premier provider of social emotional and life readiness curriculum, today announced a $6.6M Series A funding round led by Long Night Ventures, with participation from REACH Capital, Evolve Ventures, Not Boring Capital, the Designer Fund, and Oregon Venture Fund, among others.

Key Points: 
  • BERKELEY, Calif., Jan. 5, 2022 /PRNewswire-PRWeb/ -- Wayfinder , a premier provider of social emotional and life readiness curriculum, today announced a $6.6M Series A funding round led by Long Night Ventures, with participation from REACH Capital, Evolve Ventures, Not Boring Capital, the Designer Fund, and Oregon Venture Fund, among others.
  • Funds from this round will be used to help expand Wayfinder's world-class programming to millions of students across the world.
  • We are excited to support the team's leadership to bring Wayfinder to more students."
  • Wayfinder's founder and CEO Patrick Cook-Deegan says, "For years, Wayfinder has been a leader in making education more meaningful and engaging for students.

Brainomix Closes £16M ($21.2M) Financing Round to Expand Its Proven AI-Enabled Platform Beyond Stroke

Retrieved on: 
Thursday, December 16, 2021
Hospital, LinkedIn, EIS, Solution, Science and technology in Asia, Genomics, Motherboard, Clinical trial, Stroke, QQ, Diagnosis, Physician, Growth, Biomarker, Science, Imperial College London, Cancer, Stock exchange, Adoption, AI, Communication, Regenerative medicine, University, Research, Patient, Capital, Boehringer Ingelheim, Investment, NHSX, Digital health, Medtech, Twitter, Financial technology, Precision medicine, Pulmonary fibrosis, Technology, Oregon Venture Fund, Pharmaceutical industry, Medical device, Fine chemical, Tencent, Bristol, EMEA, Facebook

Brainomix has pioneered the development of an AI platform that automates validated imaging biomarkers to improve both diagnosis and treatment decisions.

Key Points: 
  • Brainomix has pioneered the development of an AI platform that automates validated imaging biomarkers to improve both diagnosis and treatment decisions.
  • Its e-Stroke platform is the world's most comprehensive stroke imaging solution and is already widely adopted in multiple healthcare systems worldwide.
  • Alastair Kilgour, Chief Investment Officer at Parkwalk Advisors, commented:
    "Over the past decade Brainomix has created the market for stroke AI imaging.
  • Its e-Stroke platform provides clinicians with the most comprehensive stroke imaging solution, driving faster treatment times and improving functional independence for patients.

Brainomix Closes £16M ($21.2M) Financing Round to Expand Its Proven AI-Enabled Platform Beyond Stroke

Retrieved on: 
Thursday, December 16, 2021
Hospital, LinkedIn, EIS, Solution, Science and technology in Asia, Genomics, Motherboard, Clinical trial, Stroke, QQ, Diagnosis, Physician, Growth, Biomarker, Science, Imperial College London, Cancer, Stock exchange, Adoption, AI, Communication, Regenerative medicine, University, Research, Patient, Capital, Boehringer Ingelheim, Investment, NHSX, Digital health, Medtech, Twitter, Financial technology, Precision medicine, Pulmonary fibrosis, Technology, Oregon Venture Fund, Pharmaceutical industry, Medical device, Fine chemical, Tencent, Bristol, EMEA, Facebook

OXFORD, UK, Dec. 16, 2021 /PRNewswire/ -- Brainomix, the AI-powered medtech solutions company, today announces that it has closed a series B financing round, raising £16M ($21.2M) to fund its expansion into new markets and new therapeutic indications, including lung fibrosis and cancer. This investment will build on the proven success of the company's tech platform in stroke and enable value-generating pharmaceutical partnerships to improve clinical trial success, foster broader adoption of existing therapies in the new indications, and improve patient outcomes.

Key Points: 
  • Brainomix has pioneered the development of an AI platform that automates validated imaging biomarkers to improve both diagnosis and treatment decisions.
  • Its e-Stroke platform is the world's most comprehensive stroke imaging solution and is already widely adopted in multiple healthcare systems worldwide.
  • Alastair Kilgour, Chief Investment Officer at Parkwalk Advisors, commented:
    "Over the past decade Brainomix has created the market for stroke AI imaging.
  • Its e-Stroke platform provides clinicians with the most comprehensive stroke imaging solution, driving faster treatment times and improving functional independence for patients.

Innosphere Ventures Fund leads investment into bioscience company, GelSana Therapeutics

Retrieved on: 
Tuesday, September 21, 2021
Technology, Therapy, Partnership, Oregon Venture Fund, Colorado School of Mines, Health, FDA, Wound healing, CO, Fund, GLOBE, CEO, Fort Collins, Colorado, Associate, Gel, Biology, Foot, General partnership, Colorado, Golden, Colorado, Pharmaceutical industry

Golden, CO and Fort Collins, CO, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Innosphere Ventures Fund (Fund), a venture capital fund leading early-stage investments, has announced its second seed-stage investment into GelSana Therapeutics (GelSana).

Key Points: 
  • Golden, CO and Fort Collins, CO, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Innosphere Ventures Fund (Fund), a venture capital fund leading early-stage investments, has announced its second seed-stage investment into GelSana Therapeutics (GelSana).
  • GelSana received a first investment from Innosphere Ventures Fund back in 2020 to accelerate their product development plan.
  • This is the first time Innosphere Ventures Fund has invested in a technology that is licensed from the Colorado School of Mines .
  • For more information on Innosphere Ventures and this investment, contact Mike Freeman, General Partner of Innosphere Ventures Fund, at [email protected] or (970) 817-4791.

Hydrolix Cloud Data Platform Helps Arkose Labs Save Money and Deliver Real-Time Insights on Millions of Fraud Attacks Daily

Retrieved on: 
Thursday, September 9, 2021
Data Management, Security, Technology, Telecommunications, Software, Internet, Hydrolix, Arkose Labs, HYDROLIX, ARKOSE LABS

Hydrolix announces today the immediate availability of a case study describing the Arkose Labs migration to the Hydrolix cloud data platform.

Key Points: 
  • Hydrolix announces today the immediate availability of a case study describing the Arkose Labs migration to the Hydrolix cloud data platform.
  • "The data challenges at Arkose Labs fit perfectly with our mission," says Marty Kagan, CEO of Hydrolix.
  • "They ingest billions of events a day, each containing hundreds of fields of sparse and complex, high-cardinality, semi-structured data.
  • Moreover, switching to Hydrolix has enabled Arkose Labs to consolidate their data infrastructure by eliminating the need for separate hot, warm and cold tiers.

Inner Loop Capital Launches $2.6M Syndicate Fund to Invest in D.C. Area Seed-Stage Founders Building Venture-Scale Companies

Retrieved on: 
Friday, June 14, 2019
Technology, Internet, Software, Security, Professional services, Finance, Finance, Money, Economy, Corporate finance, Equity securities, Entrepreneurship, Private equity, Venture capital, Oregon Venture Fund

And yet there is no institutional seed-stage venture capital fund with a mission of supporting D.C. area founders.

Key Points: 
  • And yet there is no institutional seed-stage venture capital fund with a mission of supporting D.C. area founders.
  • We hope this Syndicate Fund brings all those elements together under one roof for D.C. area founders.
  • Inner Loop will invest largely in the D.C. area, while also making investments in San Francisco and other tech hubs to encourage greater cross-pollination of ideas and capital for D.C. founders.
  • Inner Loop Capital is a seed stage venture capital investment firm committed to fueling a strong D.C. area early-stage venture market ecosystem.

Color Expands Portfolio With New Investments in Backstage Capital, BUBBLE, and More

Retrieved on: 
Thursday, May 30, 2019
Finance, Money, Economy, Entrepreneurship, Arlan Hamilton, Venture capital, Oregon Venture Fund, Backstage

PORTLAND, Ore., May 30, 2019 /PRNewswire/ -- Color , the inclusive investment fund founded by entrepreneurs Jaime Schmidt and Chris Cantino, announced investments in new portfolio companies this week including Backstage Capital and BUBBLE.

Key Points: 
  • PORTLAND, Ore., May 30, 2019 /PRNewswire/ -- Color , the inclusive investment fund founded by entrepreneurs Jaime Schmidt and Chris Cantino, announced investments in new portfolio companies this week including Backstage Capital and BUBBLE.
  • The first of Color's investments is Backstage Capital's Studio , alongside investors Arlan Hamilton and celebrity Casey Neistat.
  • Studio is currently developing products and services that engage the Backstage ecosystem in the company's goal of democratizing venture capital.
  • Additionally, Color has continued their active participation in the Oregon Venture Fund , including their recent raise for Salt & Straw and others.
    "